State-of-the-art evidence in the treatment of systemic sclerosis.

Nat Rev Rheumatol · 2023 · PMC9970138 · PMID 36849541

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not quite statistically significantno p-value reported

This approval was based on the results of the phase III focuSSced trial 41 , which demonstrated improvements in skin fibrosis that were not quite statistically significant compared with placebo; however, there was less of a decline in lung function and quantitative CT changes.

also in 341 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.